Redhill Biopharma
RDHL
#10478
Rank
S$5.17 M
Marketcap
S$1.56
Share price
1.69%
Change (1 day)
-84.47%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: S$5.17 Million

As of December 2025 Redhill Biopharma has a market cap of S$5.17 Million. This makes Redhill Biopharma the world's 10478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$5.17 M-56.94%
2024S$12.02 M-68.3%
2023S$37.93 M121.15%
2022S$17.15 M-90.61%
2021S$0.18 B-54.64%
2020S$0.40 B39.6%
2019S$0.28 B34.19%
2018S$0.21 B47.08%
2017S$0.14 B-43.37%
2016S$0.25 B11.51%
2015S$0.23 B49.61%
2014S$0.15 B60.78%
2013S$96.27 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Redhill Biopharma was reported to be:

S$5.17 Million
by Nasdaq info icon info icon
S$5.17 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$151.31 B 2,921,681.45%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$313.66 B 6,056,472.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$123.75 B 2,389,438.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
S$2.09 B 40,317.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
S$42.46 B 819,915.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel